Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

• related:
• tags: #literature
• links: PDF, source

---

Persistent Notes

Highlights

Reference

Distler O, Highland KB, Gahlemann M, et al. Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease. N Engl J Med. 2019;380(26):2518-2528. doi:10.1056/NEJMoa1903076

Links to this note

• Major pulmonary studies to know
  • [^1]: Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II) - a randomised controlled, double-blind, parallel group trial